DPP4 and diabetes mellitus: Val-boroPro, also known as PT-100, Talabostat and BXCL701, was initially synthesised as a DPP4 inhibitor for diabetes therapy but was then found to also inhibit DPP8 and DPP9 substantively (Table 1).